Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (IgG(L)-scFv) (IGLFV-134)

Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (IgG(L)-scFv) is formed by an IgG and two scFv moieties. The scFv fragments from an anti-CD89 antibody are fused to the C terminus of an anti-malaria antigen IgG light (L) chains, or vice versa. It is a type of appended IgGs, which is bispecific and tetravalent (2+2 antigen-binding valency). This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.

Datasheet INQUIRY

Specifications

Targets

CD89 & malaria antigen

Type

Appended IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Malaria

Targets

Target 1

CD89

Gene ID

2204

UniProt ID

P24071

Alternative Names

FcαRI; FCAR; Fc fragment of IgA, receptor for; CD89; FcalphaRI; immunoglobulin alpha Fc receptor; Fc alpha receptor

Target 2

malaria antigen

Alternative Names

malaria antigen; parasitic protozoans

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "CD89 & malaria antigen"

See other bsAb targets related to "CD89"

See other bsAb targets related to "malaria antigen"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (IgG(L)-scFv) (IGLFV-134). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (IgG(L)-scFv) (CAT#: IGLFV-134)

Specifications

Targets

Customer Reviews and Q&As